209 related articles for article (PubMed ID: 19495993)
1. Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide.
Kawatkar S; Wang H; Czerminski R; Joseph-McCarthy D
J Comput Aided Mol Des; 2009 Aug; 23(8):527-39. PubMed ID: 19495993
[TBL] [Abstract][Full Text] [Related]
2. Virtual fragment screening: exploration of MM-PBSA re-scoring.
Kawatkar S; Moustakas D; Miller M; Joseph-McCarthy D
J Comput Aided Mol Des; 2012 Aug; 26(8):921-34. PubMed ID: 22869295
[TBL] [Abstract][Full Text] [Related]
3. Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation.
Loving K; Salam NK; Sherman W
J Comput Aided Mol Des; 2009 Aug; 23(8):541-54. PubMed ID: 19421721
[TBL] [Abstract][Full Text] [Related]
4. Design of compound libraries for fragment screening.
Blomberg N; Cosgrove DA; Kenny PW; Kolmodin K
J Comput Aided Mol Des; 2009 Aug; 23(8):513-25. PubMed ID: 19283339
[TBL] [Abstract][Full Text] [Related]
5. Assessment of fragment docking and scoring with the endothiapepsin model system.
Herbst C; Endres S; Würz R; Sotriffer C
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2400061. PubMed ID: 38631672
[TBL] [Abstract][Full Text] [Related]
6. Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexes.
Sándor M; Kiss R; Keseru GM
J Chem Inf Model; 2010 Jun; 50(6):1165-72. PubMed ID: 20459088
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Virtual Screening of Commercially Available Compound Libraries.
Kireev D
Methods Mol Biol; 2016; 1439():65-76. PubMed ID: 27316988
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase.
Weber JE; Oakley AJ; Christ AN; Clark AG; Hayes JD; Hall R; Hume DA; Board PG; Smythe ML; Flanagan JU
Eur J Med Chem; 2010 Feb; 45(2):447-54. PubMed ID: 19939518
[TBL] [Abstract][Full Text] [Related]
9. Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.
Rudling A; Gustafsson R; Almlöf I; Homan E; Scobie M; Warpman Berglund U; Helleday T; Stenmark P; Carlsson J
J Med Chem; 2017 Oct; 60(19):8160-8169. PubMed ID: 28929756
[TBL] [Abstract][Full Text] [Related]
10. DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations.
Cuzzolin A; Sturlese M; Malvacio I; Ciancetta A; Moro S
Molecules; 2015 May; 20(6):9977-93. PubMed ID: 26035098
[TBL] [Abstract][Full Text] [Related]
11. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
[TBL] [Abstract][Full Text] [Related]
12. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
13. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
14. Lessons for fragment library design: analysis of output from multiple screening campaigns.
Chen IJ; Hubbard RE
J Comput Aided Mol Des; 2009 Aug; 23(8):603-20. PubMed ID: 19495994
[TBL] [Abstract][Full Text] [Related]
15. Ligand-based virtual screening approach using a new scoring function.
Hamza A; Wei NN; Zhan CG
J Chem Inf Model; 2012 Apr; 52(4):963-74. PubMed ID: 22486340
[TBL] [Abstract][Full Text] [Related]
16. Docking of small molecules to farnesoid X receptors using AutoDock Vina with the Convex-PL potential: lessons learned from D3R Grand Challenge 2.
Kadukova M; Grudinin S
J Comput Aided Mol Des; 2018 Jan; 32(1):151-162. PubMed ID: 28913782
[TBL] [Abstract][Full Text] [Related]
17. [Structure and function of prostaglandin D synthase].
Urade Y
Tanpakushitsu Kakusan Koso; 2008 Mar; 53(3):217-26. PubMed ID: 18326294
[No Abstract] [Full Text] [Related]
18. Docking and Virtual Screening in Drug Discovery.
Kontoyianni M
Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
[TBL] [Abstract][Full Text] [Related]
19. Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors.
Gozalbes R; Mosulén S; Carbajo RJ; Pineda-Lucena A
J Comput Aided Mol Des; 2009 Aug; 23(8):555-69. PubMed ID: 19421720
[TBL] [Abstract][Full Text] [Related]
20. Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology.
Neumann L; Ritscher A; Müller G; Hafenbradl D
J Comput Aided Mol Des; 2009 Aug; 23(8):501-11. PubMed ID: 19533372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
